Last reviewed · How we verify
Live attenuated herpes zoster vaccine — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Live attenuated herpes zoster vaccine (Live attenuated herpes zoster vaccine) — National Institute of Allergy and Infectious Diseases (NIAID).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Live attenuated herpes zoster vaccine TARGET | Live attenuated herpes zoster vaccine | National Institute of Allergy and Infectious Diseases (NIAID) | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Live attenuated herpes zoster vaccine CI watch — RSS
- Live attenuated herpes zoster vaccine CI watch — Atom
- Live attenuated herpes zoster vaccine CI watch — JSON
- Live attenuated herpes zoster vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Live attenuated herpes zoster vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/live-attenuated-herpes-zoster-vaccine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab